This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine TRAIL Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine TRAIL. It can be applied to WB and IHC assays of canine TRAIL.
Specifications
Target Information
Canine TRAIL, or TNF-related apoptosis-inducing ligand, is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. It is involved in the regulation of apoptosis, or programmed cell death, and has been studied for its potential role in the treatment of cancer. In dogs, TRAIL has been identified as a potential therapeutic target due to its ability to selectively induce apoptosis in cancer cells while sparing normal cells. This selective action makes TRAIL an attractive candidate for targeted cancer therapies in dogs, as it may help to minimize side effects often associated with traditional chemotherapy.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.